Notably, butyrate may promote oligodendrocyte differentiation and remyelination in multiple sclerosis models, whereas chronic IL-1β/IL-18 elevation in an ischaemic model predicte long-term cognitive deficits (Chen et al., 2019c,d). This evidence concerns the gene IL1B and Cognitive impairment.